FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4311531712> ?p ?o ?g. }

• W4311531712 endingPage "11" @default.
• W4311531712 startingPage "3" @default.
• W4311531712 abstract "Androgen deprivation therapy (ADT) worsens glycaemic control and cardiovascular outcomes. The prognostic value of visit-to-visit HbA1c variability (VVHV) has been unexplored in prostate cancer (PCa) patients receiving ADT. To explore the effect of ADT on VVHV and the cardiovascular prognostic value of VVHV. PCa patients receiving ADT in Hong Kong between January 1, 1993 and March 31, 2021 were included in this retrospective cohort study. Those with fewer than three HbA1c results available within 3 yr after ADT initiation, <6 mo of ADT, missing baseline HbA1c, prior diagnosis of any component of major adverse cardiovascular events (MACEs), and MACEs occurring within 3 yr were excluded. Patients were followed up until September 31, 2021. The outcome was MACEs (composite of heart failure, myocardial infarction, stroke, and cardiovascular mortality). VVHV was calculated from HbA1c levels within 3 yr after and, separately where available, before ADT initiation using coefficient of variation (CV; standard deviation [SD] divided by mean) and average real variability (ARV; average difference between consecutive measurements). Altogether, 1065 patients were analysed (median age 74.4 yr old [interquartile range 68.3–79.5 yr]). In 709 patients with VVHV available before and after ADT initiation, VVHV increased after ADT initiation (p < 0.001), with 473 (66.2%) and 474 (66.9%) having increased CV and ARV, respectively. Over a median follow-up of 4.3 yr (2.8–6.7 yr), higher VVHV was associated with a higher risk of MACEs (adjusted hazard ratio [per SD] for CV 1.21 [95% confidence interval: 1.02, 1.43], p = 0.029; ARV 1.25 [1.06, 1.48], p = 0.008). Limitations included residual confounding and selection bias. In PCa patients receiving ADT, VVHV increased after ADT initiation. Higher VVHV was associated with an increased risk of MACEs. In prostate cancer patients receiving androgen deprivation therapy (ADT), glycaemic control is less stable after initiating ADT, which was associated with an increased cardiovascular risk." @default.
• W4311531712 created "2022-12-26" @default.
• W4311531712 creator A5013965570 @default.
• W4311531712 creator A5028373986 @default.
• W4311531712 creator A5034877940 @default.
• W4311531712 creator A5039767193 @default.
• W4311531712 creator A5043518753 @default.
• W4311531712 creator A5044716183 @default.
• W4311531712 creator A5045570568 @default.
• W4311531712 creator A5046775442 @default.
• W4311531712 creator A5056600997 @default.
• W4311531712 creator A5068566752 @default.
• W4311531712 date "2023-01-01" @default.
• W4311531712 modified "2023-09-24" @default.
• W4311531712 title "HbA1c Variability and Cardiovascular Events in Patients with Prostate Cancer Receiving Androgen Deprivation Therapy" @default.
• W4311531712 cites W1502335994 @default.
• W4311531712 cites W1593932308 @default.
• W4311531712 cites W1794620829 @default.
• W4311531712 cites W1812387122 @default.
• W4311531712 cites W1970877052 @default.
• W4311531712 cites W2010480763 @default.
• W4311531712 cites W2044630684 @default.
• W4311531712 cites W2071036089 @default.
• W4311531712 cites W2098998490 @default.
• W4311531712 cites W2126680464 @default.
• W4311531712 cites W2165427196 @default.
• W4311531712 cites W2198444775 @default.
• W4311531712 cites W2810680130 @default.
• W4311531712 cites W2897218960 @default.
• W4311531712 cites W2945522282 @default.
• W4311531712 cites W2946455402 @default.
• W4311531712 cites W2959497269 @default.
• W4311531712 cites W3002613900 @default.
• W4311531712 cites W3040301052 @default.
• W4311531712 cites W3083696402 @default.
• W4311531712 cites W3086927058 @default.
• W4311531712 cites W3097158220 @default.
• W4311531712 cites W3116769837 @default.
• W4311531712 cites W3125008730 @default.
• W4311531712 cites W3127066344 @default.
• W4311531712 cites W3128646645 @default.
• W4311531712 cites W3131964654 @default.
• W4311531712 cites W3152553229 @default.
• W4311531712 cites W3158961545 @default.
• W4311531712 cites W3198154413 @default.
• W4311531712 cites W3199202358 @default.
• W4311531712 cites W4289525746 @default.
• W4311531712 cites W4293329541 @default.
• W4311531712 doi "https://doi.org/10.1016/j.euros.2022.11.002" @default.
• W4311531712 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36601042" @default.
• W4311531712 hasPublicationYear "2023" @default.
• W4311531712 type Work @default.
• W4311531712 citedByCount "0" @default.
• W4311531712 crossrefType "journal-article" @default.
• W4311531712 hasAuthorship W4311531712A5013965570 @default.
• W4311531712 hasAuthorship W4311531712A5028373986 @default.
• W4311531712 hasAuthorship W4311531712A5034877940 @default.
• W4311531712 hasAuthorship W4311531712A5039767193 @default.
• W4311531712 hasAuthorship W4311531712A5043518753 @default.
• W4311531712 hasAuthorship W4311531712A5044716183 @default.
• W4311531712 hasAuthorship W4311531712A5045570568 @default.
• W4311531712 hasAuthorship W4311531712A5046775442 @default.
• W4311531712 hasAuthorship W4311531712A5056600997 @default.
• W4311531712 hasAuthorship W4311531712A5068566752 @default.
• W4311531712 hasBestOaLocation W43115317121 @default.
• W4311531712 hasConcept C119060515 @default.
• W4311531712 hasConcept C121608353 @default.
• W4311531712 hasConcept C126322002 @default.
• W4311531712 hasConcept C164705383 @default.
• W4311531712 hasConcept C207103383 @default.
• W4311531712 hasConcept C2777899217 @default.
• W4311531712 hasConcept C2780192828 @default.
• W4311531712 hasConcept C44249647 @default.
• W4311531712 hasConcept C500558357 @default.
• W4311531712 hasConcept C50382708 @default.
• W4311531712 hasConcept C71924100 @default.
• W4311531712 hasConcept C72563966 @default.
• W4311531712 hasConceptScore W4311531712C119060515 @default.
• W4311531712 hasConceptScore W4311531712C121608353 @default.
• W4311531712 hasConceptScore W4311531712C126322002 @default.
• W4311531712 hasConceptScore W4311531712C164705383 @default.
• W4311531712 hasConceptScore W4311531712C207103383 @default.
• W4311531712 hasConceptScore W4311531712C2777899217 @default.
• W4311531712 hasConceptScore W4311531712C2780192828 @default.
• W4311531712 hasConceptScore W4311531712C44249647 @default.
• W4311531712 hasConceptScore W4311531712C500558357 @default.
• W4311531712 hasConceptScore W4311531712C50382708 @default.
• W4311531712 hasConceptScore W4311531712C71924100 @default.
• W4311531712 hasConceptScore W4311531712C72563966 @default.
• W4311531712 hasLocation W43115317121 @default.
• W4311531712 hasLocation W43115317122 @default.
• W4311531712 hasLocation W43115317123 @default.
• W4311531712 hasLocation W43115317124 @default.
• W4311531712 hasOpenAccess W4311531712 @default.
• W4311531712 hasPrimaryLocation W43115317121 @default.
• W4311531712 hasRelatedWork W1972702180 @default.
• W4311531712 hasRelatedWork W2005101102 @default.
• W4311531712 hasRelatedWork W2089715561 @default.

• next